Cameroon's MDR-TB treatment programme jeopardised by cross-border migration.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Exploring the role of wastewater-based epidemiology in understanding tuberculosis burdens in Africa.Environmental research · 2023
   Article
2. TB control in humanitarian emergencies: Lessons from the Syria displacement crisis.Journal of clinical tuberculosis and other mycobacterial diseases · 2019
   Article
3. Tuberculosis elimination: where are we now?European respiratory review : an official journal of the European Respiratory Society · 2018
   Review
4. Treating the invisible: Gaps and opportunities for enhanced TB control along the Thailand-Myanmar border.BMC health services research · 2017
   Article

Corrections and comments

• Commented on by
  Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration.2016
• Comment on
  Towards tuberculosis elimination: an action framework for low-incidence countries.2015

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as